Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models

Merck, leader in genome editing, today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based biotechnology company genOway. DARMSTADT, GERMANY genOway to acquire exclusive rights to Merck’s foundational genome-editing patents to produce, sell rodent models New technologies and solutions to be developed using CRISPR/Cas9 to accelerate delivery of better drugs to patients [...]

FairJourney Biologics ‘Future-Proofs’ Therapeutic Antibody Discovery With Geneious Biologics

AUCKLAND, NZ – Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been selected by FairJourney Biologics, a leading contract research organization (CRO), to support the company’s growth as it incorporates increasingly large Sanger data sets and next-generation sequencing (NGS) into its discovery programs. Geneious Biologics is [...]

3i and DRVISION partner to offer best in class imaging systems for life sciences

DENVER, COLORADO, USA -- 3i (Intelligent Imaging Innovations), a leading provider of advanced multimodal microscopy systems to researchers around the world, announced today a strategic partnership with DRVISION Technologies to deliver Artificial Intelligence (AI) enabled software for high-performance visualization, exploration and analysis of microscopy images of virtually any size. The partnership enables 3i to market and [...]

Spectradyne Partners with Particle Technology Labs for Measurement Services

Torrance, CA | Spectradyne is happy to announce a new partnership with Particle Technology Labs to provide analytical measurement services using its nCS1TM instrument. Particle Technology Labs is a premier analytical testing facility located in Downers Grove, Illinois, that is ISO certified to provide a broad array of measurement services. Spectradyne’s CEO Jean-Luc Fraikin described [...]

BIOASTER collaborates with Bio-Rad and Genetic Analysis to develop novel microbiome-based diagnostics within the field of metabolic disorders

Resulting new tests will help researchers investigate links between gut microbiota and diabetes and obesity BIOASTER, the French Technology Research Institute for Microbiology and Infectious Diseases, today announced the initiation of a collaborative program with BIOASTER, Bio-Rad Laboratories, Inc. and Genetic Analysis aimed at evaluating microbial dysbiosis signatures in the field of metabolic disorders. This project is a unique [...]

Igenbio Provides Automated Variant Analysis

CHICAGO--Igenbio, Inc. announced today the expansion of variant analysis service offerings. Igenbio’s comprehensive variant analysis service answers pressing questions in genome differences reflecting changes to metabolic pathways and genetic associations relevant to disease- or cancer-causing variations. Igenbio’s flagship product ERGO 2.0 enables researchers to deepen the analysis of variations with interactive visualizations enabling industrial, academic, [...]

Illumina Announces a New Genotyping Array and Scientific Contribution to Three Genome Centers to Support the All of Us Research Program

Illumina Honored to Provide Technology for Arrays and Next Generation Sequencing for Historic Research Initiative SAN DIEGO--Illumina, Inc. (NASDAQ: ILMN) today announced the launch of its new high-density genotyping array, the InfiniumTM Global Diversity Array. This new array was developed for and inspired by the All of Us Research Program. The All of Us Research Program is a historic effort [...]

BIOSURPLUS APPOINTS SHELLEY AMSTER TO ITS BOARD OF DIRECTORS | BIOSURPLUS.COM

SAN DIEGO -- BioSurplus, America's preeminent buyer and reseller of preowned lab equipment, has appointed Shelley Amster to its board of directors, bringing on a well-connected leader with extensive experience in the life science industry. "Shelley will be an excellent addition to our board," said Bill VanDeWeghe, president and CEO of BioSurplus. "Having worked with major trade organizations and [...]

Simplifying high content screening with the VIAFLO 96

INTEGRA’s VIAFLO 96 electronic multi-channel pipetting system is helping biotechnology company HCS Pharma to improve the reproducibility of high content screening using its patented BIOMIMESYS® 3D cell culture technology. Elodie Vandenhaute, Study Director at HCS Pharma, explained: "96-well cell culture plates are not easy to handle, even with multi-channel pipettes. The VIAFLO 96 is really [...]

Sartorius Supervisory Board Appoints Two New Executive Board Members

GÖTTINGEN, Germany--At today’s meeting, the Supervisory Board of Sartorius AG resolved to make changes in the Executive Board. Effective January 1, 2019, Dr. René Fáber as Head of the Bioprocess Solutions Division and Gerry Mackay as Head of the Lab Products & Services Division will be appointed new members of the company’s Executive Board. René [...]

Access IBO on Knowledge Center